BioTools Innovator Opens Applications for Second Annual Accelerator Program


– Applications Open for Companies Developing Biotechnology Products, Diagnostic and Drug Discovery Platforms, and Research and Development Services –

 – Participants Have the Opportunity to Win up to $250,000 in Non-Dilutive Funding and In-Kind Awards During 2022 Program –

LOS ANGELES, [11/29/2021] – BioTools Innovator, a new accelerator program powered by the team behind MedTech Innovator, the world’s largest accelerator of medical device startups, announced that it is now accepting applications from startups and emerging growth companies for its second annual Accelerator program. BioTools Innovator was created to advance life science tools innovation and improve human health by accelerating the growth of best-in-class startups developing and commercializing a broad spectrum of biotechnology products, platforms and services.

The four-month BioTools Innovator Accelerator program will feature 15 of the most promising early stage companies developing research tools and services for biotechnology, biomedicine, cell biology, molecular biology, genetics and biochemistry from around the globe. BioTools Innovator will offer these companies unparalleled customized education, mentorship and funding opportunities, leveraging its well-established MedTech Innovator Accelerator model. Funding to launch the BioTools Innovator program was provided by the Frederick Gardner Cottrell Foundation of Research Corporation Technologies, Inc. (RCT).

“The first year of our BioTools Innovator Accelerator program was a huge success. We look forward to continuing our successful model and growing our 2022 cohort to 15 companies developing cutting-edge life science innovations that promise to improve human health,” said Kathryn Zavala, managing director of BioTools Innovator. “BioTools Innovator helps entrepreneurs developing biotechnology products, platforms and services advance their technologies towards commercialization as quickly as possible. We are excited to see what the second year of the program has in store.”

“Early funding and access to strategic advice remains a challenge for early stage entrepreneurs in the life science industry, but the BioTools program is working to change this reality,” said Shaun Kirkpatrick, president, RCT. “We look forward to providing mentorship and support to the companies selected for the 2022 cohort as they advance some of the best ideas in the biotools area.”

“We were glad to see so many great young companies participate in the inaugural BioTools Innovator Accelerator, and we are eager to see which up-and-coming life science innovators will apply for the 2022 cohort,” said Bill Snider, partner, BroadOak Capital Partners. “As a founding sponsor of the program, BroadOak is looking forward to providing guidance and support to the 15 early stage companies selected for next year’s cohort. Together we will continue building an ecosystem that advances transformational life science research which then contributes to improving human health.”

Structured similarly to the MedTech Innovator program, applicants will progress through multiple rounds of selection, where they will have increasing exposure and visibility to stakeholders in the industry. Applications opened on Nov. 16, 2021 and will close on Jan. 31, 2022. During the first round, expert reviewers will score online applications and help determine up to 60 of the highest scoring startups selected to pitch at one of several virtual and in-person pitch events set to take place in March through May 2022. After further diligence, 15 companies will advance to receive a slot in the BioTools Innovator 2022 cohort and participate in the virtual accelerator.

The BioTools Innovator Final Competition will be held in Oct. 2022, where up to $250,000 in non-dilutive cash prizes and in-kind services will be awarded to the four selected finalists. The Grand Prize winner will be determined via a live audience vote and announced during the event. Providing financial support and individualized mentorship to startups in the BioTools program, sponsors will gain exclusive access to the database of applicants, be able to leverage shared insights with other program partners and have the opportunity to explore collaboration or potential partnerships with the participating companies.

Early stage companies looking to apply to the BioTools program can visit for more information. For inquiries about becoming a partner, please contact Kathryn Zavala, chief operating officer, MedTech Innovator, and managing director, BioTools Innovator, at


About BioTools Innovator Based in Los Angeles, Calif., BioTools Innovator was established to better the lives of patients by accelerating the growth of a broad spectrum of biotechnology products, technologies and services. BioTools Innovator matches healthcare industry leaders with innovative early stage and emerging growth biotechnology-focused companies for mentorship and support.

For more information about BioTools Innovator and to apply for a chance to be a part of the 2022 cohort, visit and follow @BTInnovator on Twitter and on LinkedIn.


About MedTech Innovator Based in Los Angeles, Calif., MedTech Innovator is the largest accelerator of medical device companies in the world and the premier nonprofit startup accelerator in the medical technology industry.[1] Its mission is to improve the lives of patients by accelerating the growth of companies that are transforming the healthcare system. MedTech Innovator matches healthcare industry leaders with innovative early stage and emerging growth medtech companies for mentorship and support.

For more information about MedTech Innovator and how to apply for the 2022 Accelerator and Showcase programs, visit and follow @MedTechAwards on Twitter and on LinkedIn. To receive industry insights and highlights about MedTech Innovator’s current and alumni participant companies, subscribe to its monthly newsletter.

[1] Gibbs, M., Johnson, B., Silva, B. A., & Berube, K. (2020, July 10). Q2 2020 Life Science Accelerators Insights Cipher Bio. Retrieved September 15, 2020, from